TRANEXAVAG TABLET contains Tranexamic Acid which belongs to the group of medicines called Antifibrinolytics. It is used in the prevention and treatment of bleeding in conditions such as heavy menstrual bleeding in women, bleeding inside the digestive system (Ex. inflammatory bowel disease), bleeding from the nose, blood in urine (not caused by the kidney (renal parenchyma)), control bleeding after dental extraction in patients with coagulopathies and after cervix surgery.
TRANEXAVAG TABLET is not recommended for use in patients with blood clotting disorder or consumption coagulopathy, kidney disease, fits or seizure disorder, irregular menstrual cycle, acquired disturbances of color vision, venous or arterial thrombosis, active thromboembolic diseases such as deep vein thrombosis, pulmonary embolism and cerebral thrombosis, subarachnoid hemorrhage and blood in urine during periods.
Before taking TRANEXAVAG TABLET, inform your doctor if you had or have changes in normal bleeding pattern, family history of endometrial cancer, abnormal bleeding between periods, bleeding during or after sexual intercourse, premenstrual pain, lower abdominal pain, bleeding after menopause, are at risk of having a blood clot, diabetic, overweight, polycystic ovary syndrome (PCOS).
TRANEXAVAG TABLET should be used with caution in pregnant and breast-feeding women only if clearly advised by the doctor. Consult your doctor before taking TRANEXAVAG TABLET. Your doctor may recommend you to take relevant tests to understand your existing condition.
Safety and effectiveness of TRANEXAVAG TABLET in children and adolescents below 18 years of age has not been established yet and it is not recommended for use in elderly women after menopause (stoppage of periods).
The most common side effects of taking TRANEXAVAG TABLET are nausea, vomiting, diarrhea, headache, tiredness and stomach pain. Consult your doctor immediately if any of the side effect worsens.